Second-line practices in the era of immunotherapy in HCC: The CHIEF cohort.

JHEP Rep · 2026 · PMC13396713 · PMID 42276189

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

Importantly, no individual TKI demonstrated clear superiority in terms of OS2, although a numerical trend toward longer PFS2 was observed with lenvatinib.

also in 723 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.